Pro Share Advisors LLC Global Blood Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$32.4 - $68.18 $23,587 - $49,635	728 Added 6.03%	12,797 $872,000
Q2 2022 Aug 01, 2022	SELL	$22.3 - $37.39 $139,486 - $233,874	-6,255 Reduced 34.14%	12,069 $386,000
Q1 2022 May 10, 2022	SELL	$25.68 - $35.59 $110,038 - $152,503	-4,285 Reduced 18.95%	18,324 $634,000
Q4 2021 Feb 08, 2022	BUY	$24.9 - $40.26 $39,914 - $64,536	1,603 Added 7.63%	22,609 $662,000
Q3 2021 Nov 12, 2021	SELL	$25.48 - $37.34 $145,439 - $213,136	-5,708 Reduced 21.37%	21,006 $535,000
Q2 2021 Aug 13, 2021	BUY	$32.46 - $43.42 $587,980 - $786,509	18,114 Added 210.63%	26,714 $936,000
Q1 2021 May 14, 2021	SELL	$38.94 - $50.85 $36,486 - $47,646	-937 Reduced 9.82%	8,600 $350,000
Q4 2020 Feb 09, 2021	SELL	$37.65 - $63.77 $13,252 - $22,447	-352 Reduced 3.56%	9,537 $413,000
Q3 2020 Nov 13, 2020	BUY	$52.76 - $74.49 $8,072 - $11,396	153 Added 1.57%	9,889 $545,000
Q2 2020 Aug 03, 2020	SELL	$48.73 - $81.82 $94,828 - $159,221	-1,946 Reduced 16.66%	9,736 $615,000
Q1 2020 May 15, 2020	SELL	$41.72 - $87.2 $383,615 - $801,804	-9,195 Reduced 44.04%	11,682 $597,000
Q4 2019 Feb 12, 2020	SELL	$45.7 - $81.86 $89,937 - $161,100	-1,968 Reduced 8.61%	20,877 $1.66 Million
Q3 2019 Nov 12, 2019	BUY	$45.35 - $57.91 $32,243 - $41,174	711 Added 3.21%	22,845 $1.11 Million
Q2 2019 Aug 13, 2019	SELL	$52.6 - $63.29 $148,384 - $178,541	-2,821 Reduced 11.3%	22,134 $1.16 Million
Q1 2019 May 15, 2019	BUY	$39.99 - $53.48 $79,460 - $106,264	1,987 Added 8.65%	24,955 $1.32 Million
Q4 2018 Feb 14, 2019	SELL	$31.54 - $46.67 $137,955 - $204,134	-4,374 Reduced 16.0%	22,968 $943,000
Q3 2018 Nov 14, 2018	SELL	$38.0 - $51.1 $38,684 - $52,019	-1,018 Reduced 3.59%	27,342 $1.04 Million
Q2 2018 Aug 13, 2018	BUY	$38.7 - $50.15 $62,694 - $81,243	1,620 Added 6.06%	28,360 $1.28 Million
Q1 2018 May 14, 2018	SELL	$39.6 - $65.9 $90,406 - $150,449	-2,283 Reduced 7.87%	26,740 $1.29 Million
Q4 2017 Feb 14, 2018	BUY	$29.7 - $45.7 $54,529 - $83,905	1,836 Added 6.75%	29,023 $1.14 Million
Q3 2017 Nov 13, 2017	BUY	$25.1 - $31.05 $38,603 - $47,754	1,538 Added 6.0%	27,187 $844,000
Q2 2017 Aug 11, 2017	BUY	N/A	25,649	25,649 $702,000

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account